Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Glucotrack Inc (GCTK)

Glucotrack Inc (GCTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,396
  • Shares Outstanding, K 911
  • Annual Sales, $ 0 K
  • Annual Income, $ -22,600 K
  • EBIT $ -15 M
  • EBITDA $ -15 M
  • 60-Month Beta 0.24
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.39 +7.51%
on 11/07/25
7.50 -22.73%
on 10/14/25
-1.89 (-24.64%)
since 10/13/25
3-Month
4.22 +37.32%
on 08/29/25
14.14 -59.02%
on 09/12/25
-0.01 (-0.09%)
since 08/13/25
52-Week
4.22 +37.32%
on 08/29/25
468.00 -98.76%
on 01/02/25
-426.21 (-98.66%)
since 11/13/24

Most Recent Stories

More News
Glucotrack, Inc. Encourages Shareholders to Vote

The  Special Meeting of Shareholders reconvenes on November 7, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund RUTHERFORD, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE)...

GCTK : 5.74 (-3.12%)
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization...

GCTK : 5.74 (-3.12%)
Glucotrack, Inc. Reminds Shareholders to Vote

The  Special Meeting of Shareholders held on October 31, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund RUTHERFORD, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE)...

GCTK : 5.74 (-3.12%)
Glucotrack to Participate in the Q3 Virtual Investor Summit

RUTHERFORD, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization...

GCTK : 5.74 (-3.12%)
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device...

GCTK : 5.74 (-3.12%)
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people...

GCTK : 5.74 (-3.12%)
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

RUTHERFORD, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people...

GCTK : 5.74 (-3.12%)
Glucotrack Announces Repurchase of Series A Warrants

GCTK : 5.74 (-3.12%)
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

GCTK : 5.74 (-3.12%)
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

GCTK : 5.74 (-3.12%)

Business Summary

GlucoTrack Inc. is an innovator of GlucoTrack(R), a non-invasive device and digital health platform for measuring glucose levels in people with Type 2 diabetes and prediabetes. GlucoTrack Inc., formerly known as Integrity Applications Inc., is based in Rutherford, NJ.

See More

Key Turning Points

3rd Resistance Point 6.36
2nd Resistance Point 6.17
1st Resistance Point 6.05
Last Price 5.74
1st Support Level 5.74
2nd Support Level 5.55
3rd Support Level 5.43

See More

52-Week High 468.00
Fibonacci 61.8% 290.84
Fibonacci 50% 236.11
Fibonacci 38.2% 181.38
Last Price 5.74
52-Week Low 4.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar